Last news
Enigmatig Reports 12.2% Revenue Growth and 68.8% Gross Margin in Fiscal 2025 Following NYSE American Listing

Enigmatig Reports 12.2% Revenue Growth and 68.8% Gross Margin in Fiscal 2025 Following NYSE American Listing

Notified -...

Invitation: Ascom 2025 Full-Year Results Conference for analysts and investors

Invitation: Ascom 2025 Full-Year Results Conference for analysts and investors

Notified -...

Tune Talk Becomes ASEAN’s First Fully Cloud-Native Mobile Network Operator with Mavenir

Tune Talk Becomes ASEAN’s First Fully Cloud-Native Mobile Network Operator with Mavenir

Notified -...

Best Places to Work Certification Recognizes Asia-Pacific Organizations for Workplace Excellence

Best Places to Work Certification Recognizes Asia-Pacific Organizations for Workplace Excellence

Notified -...

‘The Jay Walker Podcast’ to premiere Globally on Tubi this summer

‘The Jay Walker Podcast’ to premiere Globally on Tubi this summer

Notified -...

Founder Group Limited Receives NASDAQ Notification Regarding Minimum Publicly Held Shares Deficiency

Founder Group Limited Receives NASDAQ Notification Regarding Minimum Publicly Held Shares Deficiency

Notified -...

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Notified -...

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

Notified -...

1 ... 13 14 15 16 17 18 19 20 21 ... 1027
menu
menu